August 8, 2025 - 09:47

Rackspace Technology has announced its financial results for the second quarter of 2025, revealing a revenue total of $666 million. This figure marks a 3% decline compared to the same period last year. The company's private cloud segment generated $250 million, reflecting a 4% decrease year-over-year, while the public cloud revenue stood at $417 million, down 2% from the previous year.
In terms of cash flow, Rackspace reported $8 million from operating activities for the second quarter. On a trailing twelve-month basis, the cash flow from operating activities totaled $127 million, indicating a stable but cautious financial outlook. The decline in revenue across both private and public cloud segments raises questions about the company's ability to maintain growth in a competitive market.
As Rackspace continues to navigate the evolving landscape of cloud technology and artificial intelligence, stakeholders will be keenly watching how the company adapts its strategies to reverse the current downward trend in revenue.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...